1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. In Situ Hybridization Market, by Technology
6.1. Introduction
6.2. Chromogenic In Situ Hybridization
6.3. Fluorescence In Situ Hybridization
6.3.1. DNA Fluorescence In Situ Hybridization
6.3.2. PNA Fluorescence In Situ Hybridization
6.3.3. RNA Fluorescence In Situ Hybridization

7. In Situ Hybridization Market, by Product
7.1. Introduction
7.2. Consumables
7.2.1. Accessories
7.2.2. Kits & Reagents
7.2.3. Probes
7.3. Instruments
7.4. Software

8. In Situ Hybridization Market, by Application
8.1. Introduction
8.2. Cancer Diagnostics
8.3. Cytology
8.4. Immunology
8.5. Infectious Disease Diagnostics
8.6. Neuroscience

9. In Situ Hybridization Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Hospital & Diagnostic Laboratories
9.5. Pharmaceutical & Biotechnology Companies

10. California In Situ Hybridization Market

11. Florida In Situ Hybridization Market

12. Illinois In Situ Hybridization Market

13. New York In Situ Hybridization Market

14. Ohio In Situ Hybridization Market

15. Pennsylvania In Situ Hybridization Market

16. Texas In Situ Hybridization Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Abbott Laboratories
18.2. Abcam PLC
18.3. Abnova Corporation
18.4. Agilent Technologies, Inc.
18.5. Bio SB
18.6. Bio-Rad Laboratories, Inc.
18.7. Bio-Techne Corporation
18.8. Biocare Medical, LLC
18.9. Biocat GmbH
18.10. Biogenex Laboratories
18.11. Creative Bioarray
18.12. Danaher Corporation
18.13. Enzo Life Sciences, Inc.
18.14. F. Hoffmann-La Roche Ltd
18.15. Genemed Biotechnologies, Inc.
18.16. Merck KGaA
18.17. OpGen Inc.
18.18. PerkinElmer Inc.
18.19. Qiagen N.V.
18.20. Thermo Fisher Scientific Inc.
18.21. ZytoVision GmbH

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES IN SITU HYBRIDIZATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES IN SITU HYBRIDIZATION MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 6. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY DNA FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY DNA FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PNA FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PNA FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY RNA FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY RNA FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 17. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2027
FIGURE 19. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY ACCESSORIES, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY ACCESSORIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY KITS & REAGENTS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PROBES, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PROBES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY INSTRUMENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY SOFTWARE, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY SOFTWARE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 32. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2027
FIGURE 34. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CANCER DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CYTOLOGY, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CYTOLOGY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY NEUROSCIENCE, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY NEUROSCIENCE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 45. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2027
FIGURE 47. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
FIGURE 48. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2027 (USD MILLION)
FIGURE 50. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 52. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
FIGURE 54. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES IN SITU HYBRIDIZATION MARKET: FPNV POSITIONING MATRIX
FIGURE 56. UNITED STATES IN SITU HYBRIDIZATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES IN SITU HYBRIDIZATION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES IN SITU HYBRIDIZATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY DNA FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PNA FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY RNA FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY ACCESSORIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PROBES, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY SOFTWARE, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CYTOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY NEUROSCIENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES IN SITU HYBRIDIZATION MARKET: SCORES
TABLE 28. UNITED STATES IN SITU HYBRIDIZATION MARKET: BUSINESS STRATEGY
TABLE 29. UNITED STATES IN SITU HYBRIDIZATION MARKET: PRODUCT SATISFACTION
TABLE 30. UNITED STATES IN SITU HYBRIDIZATION MARKET: RANKING
TABLE 31. UNITED STATES IN SITU HYBRIDIZATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 32. UNITED STATES IN SITU HYBRIDIZATION MARKET: MERGER & ACQUISITION
TABLE 33. UNITED STATES IN SITU HYBRIDIZATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 34. UNITED STATES IN SITU HYBRIDIZATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 35. UNITED STATES IN SITU HYBRIDIZATION MARKET: INVESTMENT & FUNDING
TABLE 36. UNITED STATES IN SITU HYBRIDIZATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 37. UNITED STATES IN SITU HYBRIDIZATION MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Abcam PLC
Abnova Corporation
Agilent Technologies, Inc.
Bio SB
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Biocare Medical, LLC
Biocat GmbH
Biogenex Laboratories
Creative Bioarray
Danaher Corporation
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche Ltd
Genemed Biotechnologies, Inc.
Merck KGaA
OpGen Inc.
PerkinElmer Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
ZytoVision GmbH